NASDAQ: XYLO
Xylo Technologies Ltd Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their XYLO stock forecasts and price targets.

Forecast return on equity

Is XYLO forecast to generate an efficient return?

Company
1,200.1%
Industry
17.76%
Market
65.64%
XYLO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XYLO forecast to generate an efficient return on assets?

Company
464.07%
Industry
9.3%
XYLO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XYLO earnings per share forecast

What is XYLO's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$6.32

XYLO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
XYLO$4.50N/AN/A
RSLS$4.53N/AN/A
HSCS$3.45$13.50+291.30%Strong Buy
AMIX$2.96N/AN/A
VTAK$0.46N/AN/A

Xylo Technologies Stock Forecast FAQ

What is XYLO's earnings growth forecast for 2025-2025?

(NASDAQ: XYLO) Xylo Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Xylo Technologies's earnings in 2025 is -$18,374,000.

In 2025, XYLO is forecast to generate $182,343,130 in earnings, with the lowest earnings forecast at $182,343,130 and the highest earnings forecast at $182,343,130.

If you're new to stock investing, here's how to buy Xylo Technologies stock.

What is XYLO's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: XYLO) forecast ROE is 1,200.1%, which is considered strong.

What is XYLO's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: XYLO) Xylo Technologies's current Earnings Per Share (EPS) is -$23.20. In 2025, XYLO's EPS is forecast to hit $6.32 (min: $6.32, max: $6.32).

What is XYLO's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: XYLO) forecast ROA is 464.07%, which is higher than the forecast US Medical Devices industry average of 9.3%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.